Asia-Pacific Infusion Pumps Market, By Type (Traditional Infusion Pumps, Specialty Infusion Pumps), Accessories and Consumables (Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps, Infusion Catheters, IV/Administration Sets, Needleless Connectors, Cannulas, Tubing and Extension Sets, Valves, Others), Application (Hemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Paediatrics/Neonatology, Haematology, Other), End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes) – Industry Trends and Forecast to 2030.
Asia-Pacific Infusion Pumps Market Analysis and Size
The Asia-Pacific infusion pumps market is a dynamic and rapidly evolving sector within the healthcare industry. Infusion pumps are crucial medical devices used to administer fluids, medications, and nutrients to patients in a controlled and precise manner. This market in the Asia-Pacific region is driven by several factors, including the increasing prevalence of chronic diseases, a growing aging population, and a rising demand for advanced healthcare solutions. The need for efficient and accurate drug delivery systems is propelling the adoption of infusion pumps in hospitals, clinics, and home healthcare settings across the region. Technological advancements, such as the integration of smart features and wireless connectivity, are enhancing the overall functionality and usability of infusion pumps. Moreover, healthcare providers are focusing on reducing healthcare costs and improving patient outcomes, which further boosts the demand for innovative infusion pump solutions.
Data Bridge Market Research analyses that the Asia-Pacific infusion pumps market which was USD 4.40 billion in 2022, is expected to reach USD 6.67 billion by 2030, and is expected to undergo a CAGR of 4.9% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Infusion Pumps Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Traditional Infusion Pumps, Specialty Infusion Pumps), Accessories and Consumables (Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps, Infusion Catheters, IV/Administration Sets, Needleless Connectors, Cannulas, Tubing and Extension Sets, Valves, Others), Application (Hemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Paediatrics/Neonatology, Haematology, Other), End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes)
|
|
Countries Covered
|
Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific
|
|
Market Players Covered
|
BD (Becton, Dickinson and Company) (U.S.), B. Braun Melsungen AG (Germany), Baxter (U.S.), Fresenius Kabi AG (Germany), ICU Medical, Inc. (U.S.), Smiths Group PLC (U.K.), Medtronic (U.S.), Moog Inc. (U.S.), Terumo Corporation (Japan), Avanos Corporate (U.S.), NIPRO (Japan), Insulet Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), JMS Co. Ltd. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Infusion pumps are medical devices used to deliver fluids, such as medications, nutrients, or other therapeutic substances, into a patient's body in a controlled and precise manner. These devices are crucial in healthcare settings, including hospitals, clinics, and home healthcare, to administer fluids intravenously (IV), subcutaneously, or epidurally. The infusion pump accurately controls the rate and volume of the fluid being delivered, ensuring that patients receive the prescribed dose at the correct speed and duration. This precision is vital for medications that require specific infusion rates or for patients with critical medical conditions.
Asia-Pacific Infusion Pumps Market
Drivers
- Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders in the Asia-Pacific region is a major driver for the infusion pumps market. Infusion pumps play a vital role in the continuous and precise administration of medications for managing chronic conditions, thereby propelling the demand for these devices.
- Technological Advancement and Innovation
Ongoing advancements in infusion pump technology, including the development of smart infusion systems, integration of wireless connectivity, enhanced safety features, and the ability to administer multiple therapies simultaneously, are driving market growth. These technological innovations are improving the accuracy, efficiency, and safety of infusion pumps, encouraging their adoption in healthcare settings across the Asia-Pacific region.
Opportunity
- Rapidly Growing Home Healthcare Market
The expanding home healthcare sector in the Asia-Pacific region presents a significant opportunity for the infusion pumps market. Increasing preference for home-based care due to its convenience, cost-effectiveness, and the growing elderly population requiring long-term care encourages the use of infusion pumps in a home setting. Infusion pumps enable controlled and monitored drug administration outside of healthcare facilities, aligning with the trend of shifting healthcare from hospitals to homes.
Restraint/Challenge
- High Cost of Infusion Pumps System
The high initial cost of infusion pump systems, including the device itself, accessories, and maintenance, can act as a restraint for market growth in the Asia-Pacific region. The affordability and cost-effectiveness of these devices pose challenges for adoption, particularly in emerging economies where healthcare budgets may be constrained. Cost-sensitive markets may require targeted strategies to address price concerns and ensure wider accessibility of infusion pump technologies.
This Asia-Pacific infusion pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific infusion pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2022, ICU Medical Inc. declared that the purchase of Smiths Medical from Smiths Group plc had been completed. Syringe and ambulatory infusion devices, vascular access, and essential care products are all part of the Smiths Medical business. The combined businesses, when combined with ICU Medical's current businesses, create a market-leading infusion therapy company with pro forma combined revenues of about USD 2.5 billion
Asia-Pacific Infusion Pumps Market Scope and Market Size
The Asia-Pacific infusion pumps market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterilization Products
- Cleaning and Disinfection Products
- Personal Protective Barriers
- Endoscope Reprocessing Products
- Anti-microbial Surfaces
- Other Infusion Pumps Products
Application
- Surgical Instruments
- Endoscopes
- Ultrasound Probes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
End User
- Hospitals
- Clinics
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Laboratories
- Others
Asia-Pacific Infusion Pumps Market Regional Analysis/Insights
The Asia-Pacific infusion pumps market is analysed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.
The countries covered in the Asia-Pacific infusion pumps market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the Asia-Pacific infusion pumps market due to the rise in the efforts by the established companies. Furthermore, the steady number of strategic associations adopted by key market players will further boost the growth of the Asia-Pacific infusion pumps market.
Asia-Pacific is projected to observe significant amount of growth and the fastest growing region in the Asia-Pacific infusion pumps market during the forecast period of 2023 to 2030, market due to the rise in the occurrence of outsourcing organizations. Moreover, the increasing healthcare expenses is further anticipated to propel the growth of the Infusion Pumps Market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Asia-Pacific infusion pumps market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific infusion pumps market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific infusion pumps market. The data is available for historic period 2015-2020.
Competitive Landscape and Asia-Pacific Infusion Pumps Market Share Analysis
The Asia-Pacific infusion pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific infusion pumps market.
Some of the major players operating in the Asia-Pacific infusion pumps market are:
- BD (Becton, Dickinson and Company) (U.S.)
- B. Braun Melsungen AG (Germany)
- Baxter (U.S.)
- Fresenius Kabi AG (Germany)
- ICU Medical, Inc. (U.S.)
- Smiths Group PLC (U.K.)
- Medtronic (U.S.)
- Moog Inc. (U.S.)
- Terumo Corporation (Japan)
- Avanos Corporate (U.S.)
- NIPRO (Japan)
- Insulet Corporation (U.S.)
- Tandem Diabetes Care, Inc. (U.S.)
- JMS Co. Ltd. (Japan)
- F. Hoffmann-La Roche Ltd. (Switzerland)
SKU-